FML Forte Liquifilm Interactions
There are 42 drugs known to interact with FML Forte Liquifilm (fluorometholone ophthalmic), along with 2 disease interactions. Of the total drug interactions, 1 is major, and 41 are moderate.
- View all 42 medications that may interact with FML Forte Liquifilm
- View FML Forte Liquifilm disease interactions (2)
Most frequently checked interactions
View interaction reports for FML Forte Liquifilm (fluorometholone ophthalmic) and the medicines listed below.
- acebutolol
- acetaminophen
- acetaminophen / hydrocodone
- Airborne (multivitamin with minerals)
- alpha-lipoic acid
- amlodipine
- amoxicillin
- aripiprazole
- Artificial Tears (ocular lubricant ophthalmic)
- aspirin
- Astelin (azelastine nasal)
- atorvastatin
- Bactroban (mupirocin topical)
- Benadryl (diphenhydramine)
- betamethasone
- Brilinta (ticagrelor)
- brimonidine / timolol ophthalmic
- calcium / vitamin d
- furosemide
- gabapentin
- hydrochlorothiazide / lisinopril
- levothyroxine
- losartan
- metformin
- Prevacid (lansoprazole)
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- Restasis (cyclosporine ophthalmic)
- Vitamin D2 (ergocalciferol)
- Vitamin D3 (cholecalciferol)
- warfarin
FML Forte Liquifilm disease interactions
There are 2 disease interactions with FML Forte Liquifilm (fluorometholone ophthalmic) which include:
More about FML Forte Liquifilm (fluorometholone ophthalmic)
- FML Forte Liquifilm consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: ophthalmic steroids
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.